About

Maria Hordinsky, MD, is the R. W. Goltz Professor in the Department of Dermatology at the University of Minnesota. She is a tenured faculty member, Vice Chair of Research, and Immediate Past Chair of the Department, a position she supported for 23 years. Dr. Hordinsky is recognized for her expertise and research in hair diseases and the peripheral nervous system as it relates to hair follicle biology. She recently completed a five-year term as a member of the Board of Directors of the American Academy of Dermatology and is a member of the Board of Directors of the Scarring Alopecia Foundation. She is also a Past President of the American Hair Research Society (North, South, Central) and the Association of Professors of Dermatology. Dr. Hordinsky has received the Leonard Tow Humanism in Medicine Award and has over 200 publications. She regularly lectures and teaches on hair diseases and divides her time between seeing patients with residents and medical students in her clinical practice associated with University of Minnesota Physicians, doing clinical research, teaching, and administration.

Research topics

• Medicine
• Dermatology
• Pathology
• Family medicine
• Political Science
• Intensive care medicine
• Artificial Intelligence
• Internal medicine
• Medical education
• Social psychology
• Physical therapy
• Psychology
• Surgery
• Psychiatry

Selected publications

• Assessing workload, compensation, and burnout in academic dermatology: a national multi-institutional survey study

  International Journal of Women’s Dermatology · 2026-02-11

  articleOpen access

  Background: Academic dermatologists manage a broad array of responsibilities, often extending beyond clinical duties to include education, research, mentorship, and administrative work. Objective: This study aimed to quantify the scope of paid and unpaid responsibilities among academic dermatologists in the United States and identify disparities based on gender, career stage, and geography. Methods: A cross-sectional survey of 63 board-certified academic dermatologists from 12 institutions collected data on demographics, workweek allocation, after-hours tasks, compensation, burnout, and resilience from January to May 2025. Results: Respondents reported spending 58.3% of their time on clinical care, 15.9% on administrative duties, 13.8% on education, and 11.9% on research. Nearly half received 11 to 50 daily patient messages via the clinical inbox, and over 80% took hospital call duties, with most receiving no extra compensation. Burnout affected 63.5% of respondents and was significantly more prevalent among women, early-career physicians, and those in the Mid-Atlantic and Northeast regions. Resilience scores were lower among women. Consulting opportunities, often associated with supplemental income and career advancement, were more common among male and senior physicians. Parental leave policies were inconsistently applied and poorly understood; nearly 20% of respondents had 8 or fewer weeks of paid parental leave. Limitations: Study limitations include the relatively small sample size and overrepresentation of the Northeast region, potentially hindering generalizability. Additionally, no significant race-based differences were observed, which may be due to insufficient sample sizes within comparator groups. Conclusion: These findings highlight the cumulative burden of undercompensated labor, inadequate institutional support, and gender disparities in workload and opportunity. Structural changes in compensation transparency, workload distribution, recognition of academic labor, and support for early-career and female physicians are essential to fostering sustainability and equity within academic dermatology.

  PublisherDOI

• 63170 Analysis of oral, topical, and compounded minoxidil prices and insurance coverage

  Journal of the American Academy of Dermatology · 2025-09-01

  article
  PublisherDOI

• 0301 Quality of life impairment is present in some but not all patients with frontal fibrosing alopecia

  Journal of Investigative Dermatology · 2025-07-21

  articleOpen accessSenior author
  PublisherOA PDFDOI

• Commonly Prescribed Hair Loss Treatments Are Rarely Designated as Dermatologic Agents by Insurance Companies.

  PubMed · 2025-08-01

  article
  Publisher

• Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)

  SKIN The Journal of Cutaneous Medicine · 2025-11-10

  articleOpen access

  In 24-week, placebo-controlled period (Period A) of Study 1 and Study 2 of the phase 3 UP-AA program, both UPA 15 mg and UPA 30 mg demonstrated superior and high degrees of efficacy in adults and adolescents with severe AA, compared with placebo The safety profile of both doses of UPA in Period A was generally consistent with that observed in approved indicationsThe efficacy, safety, and tolerability of UPA in adult and adolescent patients with severe AA will be further evaluated in the ongoing UP-AA phase 3 clinical program To obtain a PDF of this posterScan QR code or use the following link to download an electronic version of this presentation and other AbbVie Fall Clinical 2025 scientific presentations https://abbvie1.outsystemsenterprise.com/CongressPublications/ CongressHome?CongressId=b8758441-99a9-4a04-a4c8-75ef968362d3

  PublisherOA PDFDOI

• Testing for methicillin-resistant <i>Staphylococcus aureus</i> in the anterior nares for antibiotic de-escalation in patients presenting with acute skin and soft tissue infections: systematic review and meta-analysis

  Infection Control and Hospital Epidemiology · 2025-04-16 · 1 citations

  articleOpen accessSenior author

  OBJECTIVE: (MRSA) colonization of the nares to predict MRSA in acute skin and soft tissue infections (SSTIs). METHODS: This meta-analysis was performed according to PRISMA guidelines. Six databases were searched by two reviewers for articles on MRSA detection in the nares and acute SSTIs. The quality and risk of bias of the articles were then assessed. The primary outcomes of interest were pooled sensitivity and specificity. Sub-analyses were also performed to test for heterogeneity. RESULTS: After screening 1040 records, 15 articles (n = 1,970) were included in the meta-analysis. Using MRSA nares screening to predict MRSA in acute SSTIs had an overall specificity of 0.949 and sensitivity of 0.474. With a prevalence of 29.1%, the calculated NPV was 0.815. There were sub-analyses on various study variables, such as study location, participant age, and detection by polymerase chain reaction versus culture. The only significant finding was an increased sensitivity for adults (0.543) compared to pediatric participants (0.285). DISCUSSION: To our knowledge, this is the first meta-analysis that focuses on the performance of MRSA nares screening for predicting MRSA infection in patients presenting with acute SSTIs. The baseline prevalence of MRSA SSTIs is important for interpreting the screening results, and the prevalence is influenced by geography and patient factors. This clinical context must be considered before utilizing MRSA nares screening for acute SSTIs.

  PublisherOA PDFDOI

• 0095 3D imaging of central centrifugal cicatricial alopecia treated with 6% topical gabapentin demonstrates re-innervation of the epidermis

  Journal of Investigative Dermatology · 2025-07-21

  articleSenior author
  PublisherDOI

• 64567 Quantitative evaluation of disease activity and hair counts pre- and post-allergy testing in patients with frontal fibrosing alopecia and lichen planopilaris

  Journal of the American Academy of Dermatology · 2025-09-01

  articleSenior author
  PublisherDOI

• Response to Ezzat et al, “response to Rypka et al, ‘A single-center retrospective cohort study of hydroxychloroquine-related adverse events in adults with lymphocytic cicatricial alopecia’”

  Journal of the American Academy of Dermatology · 2025-06-11 · 1 citations

  letter
  PublisherDOI

• Multidisciplinary Dermatology: A Framework from the Association of Academic Cosmetic Dermatology.

  PubMed · 2025-06-01

  article

  Cross-specialty collaboration can be helpful in the treatment of patients with complex medical conditions involving dermatologic manifestations. This article underscores the utility of multidisciplinary collaboration through discussion of seven hypothetical case scenarios, including patient care in the clinical contexts of hidradenitis suppurativa, venous varicosities, scleroderma, gender-affirming care, sequelae from cancer, solid organ transplantation, and neurocutaneous syndromes. Through these cases, we highlight how a holistic healthcare approach that encompasses multiple specialties can positively contribute to dermatologic patient care.

  Publisher

Frequent coauthors

• Wilma F. Bergfeld

  Cleveland Clinic

  93 shared

• Elise A. Olsen

  83 shared

• Janet L. Roberts

  Oregon Dermatology & Research Center

  81 shared

• Jerry Shapiro

  New York University

  79 shared

• Ken Washenik

  75 shared

• Andrew G. Messenger

  University of Sheffield

  72 shared

• David A. Whiting

  66 shared

• Dow B. Stough

  66 shared

Education

• Dermatology Residency , Dermatology

  University of Minnesota

  1980

Awards & honors

• Leonard Tow Humanism in Medicine Award
• Past President of the American Hair Research Society (North,…